Effect of Intercostal Nerve Block With Ropivacaine Combined With Mecobalamine on Chronic Pain After Thoracic Surgery

Xuzhou Medical University

Status: Unknown

Conditions: Postoperative Pain

Treatments: Procedure: Intercostal nerve block

Study type: Interventional

Funder types: Other

Identifiers

NCT04217213

XYFY2019-KL169-01

Details and patient eligibility

About

This project intends to investigate the effects of intercostal nerve block with ropivacaine combined with mecobalamin on chronic post-surgical pain (CPSP) in thoracic postoperative patients. Related clinical characteristics of postoperative chronic pain. The results of the study provide clinicians with a simple and inexpensive new method of preventing CPSP, in order to prevent the occurrence of CPSP and reduce the incidence of CPSP, thereby reducing CPSP to patients and their families, hospitals. And public resources.

Enrollment: 124 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≥18 years old, conscious;
2. ASA class Ⅰ ~ Ⅲ;
3. Thoracoscopic lobectomy was proposed;
4. The han nationality;
5. Native speaker of Chinese;
6. Agree to participate in this study and sign the informed consent.

Exclusion criteria

1. Patients allergic to meccobalamin or ropivacaine;
2. Patients with previous history of chest surgery;
3. Patients with tumor invasion of chest wall, abscess, tumor intercostal neuropathy or pathological rib fracture;
4. Patients with a history of analgesic addiction or abuse, epilepsy, one or other neurological disease;
5. Diabetic patients;
6. Patients who need other drugs for pain relief but have not completed treatment or have completed treatment.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

124 participants in 2 patient groups

ropivacaine combined with mecobalamine

Experimental group

Description:

Intercostal nerve block with 0.5% ropivacaine combined with mecobalamine (0.5mg).

Treatment:

Procedure: Intercostal nerve block

ropivacaine

Active Comparator group

Description:

Intercostal nerve block with 0.5% ropivacaine alone.

Treatment:

Procedure: Intercostal nerve block